Retrospective Chart Review of Subcutaneous IgG Use in Infants

Inclusion Criteria: * Infants who received more than one dose of IgG by the subcutaneous route before the age of two years. * Consent of parent/guardian if required by institution/IRB. Exclusion Criteria: * Infants with protein losing conditions such as lymphangiectasis, nephrosis, S/P cardio-thoracic surgery requiring drainage tubes for more than 48 hrs, protein losing enteropathy. * Concomitant treatment with plasma, other blood products or IGIV while on SCIG. * Lack of consent by parent/guardian (if required by Institution/IRB). * Any other condition or treatment which, in the opinion of the local investigator, would interfere with obtaining valid results for that subject.